chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a healthcare worker refers to a patient of unknown age. On 14-FEB-2013 the patient was vaccinated with improperly stored VARIVAX (Merck) (lot # H018015; expired date: 14-OCT-2013) (dose and route unspecified). The vaccine was stored in refrigeration under 45 degrees Fahrenheit from 07-FEB-2013 to 27-FEB-2013. The outcome of the event was unknown. No adverse effect reported. This is one of three reports from the same reporter. The MARRS# of the other two reports are 1303USA000094 and 1302USA013682. Additional information has been requested.
Pt's husband called and said after their walk today patient was presenting  with shortness of breath  and tiredness and fatique.
This spontaneous report as received from a journalist refers to a young female patient of unknown age. On an unknown date, the patient was vaccinated with a dose or doses of GARDASIL (route, dose and lot # not reported). On an unknown date, the patient experienced paralyzed from the waist down after receiving GARDASIL. At the time of the report, the patient's outcome was unknown. The reporter considered paralyzed from the waist down to be disabling. Upon internal review paralyzed from the waist down was considered to be medically significant. Additional information is not expected.
Information has been received from a registered nurse concerning a male patient who on an unspecified date was vaccinated with a dose of PNEUMOVAX 23 (lot# 664864/1365Y). Subsequently, the patient developed injection site reaction after receiving PNEUMOVAX 23. The patient developed arm swelling, redness and pain. It was unknown if the patient sought medical attention. The patient was not hospitalized. At the time of the report, the patient's status was unknown. Follow-up information was received from the registered nurse concerning an 81 year old male patient with no known drug allergies, hypertension, coronary artery disease (CAD) and renal dysfunction and a history of colon polyps who on 06-JAN-2010 was vaccinated with recent dose of PNEUMOVAX 23 in his left arm. Concomitant therapy included TOPROL XL tablets, simvastatin, lisinopril, aspirin, niacin, nitroglycerin and HYDRODIURIL. No other vaccines were given. It was reported that there were no serious criteria. At the time of the report, the patient was fully recovered. This is on of several reports received from the same source. No further information is available.
Experiencing post  vaccine: headaches; chills; brain fog; muscle aches; arthritis more painful; lethargy;
The symptom's that I got was like inflammation in my chest and then it will go away, then probably come back in 10 minutes 15 minutes later; I was like that for three days having that inflammation; This is a spontaneous report received from a contactable consumer (patient). A female patient of unspecified age received BNT162B2 (solution for injection), via an unspecified route of administration on 29May2021 as unknown dose, single for covid-19 immunisation. The patient's medical history and concomitant medications was not reported. On an unspecified date in 2021 the patient experienced inflammation in her chest for a while and got relived, after half an hour she experienced the same symptoms and it continued till 3 days. So the patients concern was she want to received her 2nd dose, and she want to know anybody or any case or by experience or any report that people get these type of side effects or symptoms." The outcome of the event was not recovered.  LOT NUMBER#: Consumer stated, "Let me call other sometime, as I am running out of time then I have my appointment then I need to find out a little more about, my next shot."  Follow-up attempts are possible. Information about Lot/Batch number has been requested.
This 21-year-old pt received vax 12/1998. Serum alanine and serum aspartate tests revealed elevated levels. The pt sought unspecified medical attention. Subsequently, the pt's levels returned to normal range. No further information is available.
Initial report received from Healthcare professional on 03 November 2014. A 9 adult patient, whose medical history and concomitant medications were not reported, had received an intradermal dose of FLUZONE (Batch number UT4993BA, expiry date and dose number was not reported) in the deltoid on 30 October 2014. The patient had developed red welt big as a silver dollar at the injection site on 30 October 2014. Lab investigations were not reported and advice to take BENADRYL, ADVIL. The reaction was lasted up to 72 Hour. The patient had no illness at the time of vaccination, pre-existing diagnosed allergies and birth defects were not reported. At the time of this report the outcome of the event was resolved. List of documents held by sender: none.
Information has been received from a registered (RN) concerning a 9-year-old female who on 05-DEC-1997 was vaccinated SC in the right arm with a 0.5 mL first dose of Varivax (Lot #622625/0085E). The RN reported that on 17-MAY-2006, the patient developed less than 50 lesions. Unspecified medical attention was sought, but no treatment was required. By 24-MAY-2006, the patient had recovered and returned to school. No additional information is available.
Cheeks were swelling; Eyes were swelling; Low grade fever; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of SWELLING FACE (Cheeks were swelling), EYE SWELLING (Eyes were swelling) and PYREXIA (Low grade fever) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in 2020 and Dermal filler injection in 2020.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced SWELLING FACE (Cheeks were swelling), EYE SWELLING (Eyes were swelling) and PYREXIA (Low grade fever). At the time of the report, SWELLING FACE (Cheeks were swelling), EYE SWELLING (Eyes were swelling) and PYREXIA (Low grade fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment medication included Paracetamol around the clock on 07-Jan-2021 for the event low grade fever.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This spontaneous report as received from a Registered Nurse refers to a 75 year old male patient. Pertinent medical history, concomitant medication, drug reactions and allergies were unspecified by the reporter. On 24-MAR-2014 the patient was vaccinated with a 0.65 ml dose of ZOSTAVAX (lot # J006831, expiration date 14-SEP-2014), subcutaneously. On unknown date in 2014 (reported as recently), the patient was diagnosed with shingles. The outcome of shingles was reported as not recovered. The patient sought medical attention via office visit to unspecified physician. The relatedness between shingles and ZOSTAVAX was not provided. Additional information has been requested.
COVID-19 vaccine: "Rash, pruritis, Improved with 25 mg benadryl but did not fully recover"
Severe pain rt side of trunk Nov 2013. 4-6 nerve blocks. 2 epidural injection. LYRICA now Nortiptyline daily 50 mg.
Almost lost my son from the vaccine; This case was reported by a consumer via interactive digital media Facebook and described the occurrence of near death experience in a male patient who received Men B NVS (Bexsero) for prophylaxis.  On an unknown date, the patient received Meningococcal B vaccine at an unknown dose. On an unknown date, unknown after receiving Meningococcal B vaccine, the patient experienced near death experience (serious criteria GSK medically significant). On an unknown date, the outcome of the near death experience was unknown.   The reporter considered the near death experience to be related to Meningococcal B vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient's parent reported that, it was tough one that almost lost his son from  the vaccine.
August 26, 2011 Patient had the Hep A & B booster shot at Dr's office. August 27, 2011 Tiny red spots and some itchiness began to appear. August 28 & 29 2011 The small spots became much enlarged and spread throughout the body and face and neck. Family Doctor prescribed anti-histamine but this was too strong for patient. A persistent cough ensued with occasional chest wheezing at night. An increase in edema occurred, with swelling of legs, ankles and abdomen. September 23, 2011 Previous weeks, water retention had become worse and increase in weight to 152 lbs. Rash subsided after 2 weeks. We received a message from Dr's nurse that the vaccine can cause an allergic reaction for someone with latex allergy. Patient has an allergy to band aids or latex adhesive so we must assume that she had a reaction to the 2nd vaccine shot. The nurse said patient should not have the 3rd and final shot in 5 months time. At around this period, patient also began to suffer from severe lack of  bladder control. Persistent coughing continued, blood pressure levels increased requiring extra medication. Abdomen bloating, and incontinence. Increased doses of Furosimide were ineffective.
This is a spontaneous report from a contactable consumer (patient). A 66-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6207), via an unspecified route of administration, administered in left arm on 25Mar2021 at 15:45 (at the age of 66-years-old) as 2nd single dose for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient medical history was not reported. The patient concomitant medication taken in two weeks included alprazolam (XANAX), cefixime (FLEXERIL [CEFIXIME]), hydrocodone bitartrate, paracetamol (NORCO), piroxicam (PAXIL [PIROXICAM]) all taken for an unspecified indication. The patient did not receive other vaccine in four weeks. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: En6202), via an unspecified route of administration, administered in left arm on 09Mar2021 at 15:45 (at the age of 66-years-old) as a single dose for covid-19 immunisation. On 26Mar2021 04:00 the patient experienced fever blister. Patient enquired it was okay to take Acyclovir 800mg, 3 times a day, starting 18 hours after2nd Covid vaccine or would it cause the vaccine to not work. Patient reported that still have to wear a mask so don't mind putting off taking acyclovir unless the fever blisters get worse and patient gets them a lot. Patient don't think the vaccine causes them for people who never had them and was just wondering if it could activate them. Patient received Acyclovir as treatment. The outcome of the event was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a pharmacist refers to a male patient of unknown age. On 12-JUN-2013 the patient was vaccinated with a dose of ZOSTAVAX (strength, dose, frequency and lot number were not reported). On 13-JUN-2013 the patient experienced itching at the injection site. Patient sought medical attention - he presented to the reporting pharmacist at the pharmacy. The outcome of itching at the injection site was reported as not recovered. The relatedness between itching at the injection site and ZOSTAVAX was not reported. Additional information has been requested.
Second Pfizer Co Vid vaccine given too soon (given at 14 days out instead of 21 days).  No harm to patient
Headache, Sedation, Myalgia, ErythemaMultiform,Diarrhea,  CHILLS AND PAIN Narrative:
Moderna COVID-19 Vaccine EUA  I have had a bad taste in my mouth since the vaccine was injected.
Extreme soreness and muscle weakness in the left arm. Painful range of motion, inability to raise the arm above shoulder height; inability to use the arm for simple tasks for a week or more. Extreme soreness in left chest and left back for 2 weeks, tapering down to moderate soreness for 4-5 weeks. Extreme soreness on top of shoulder, extending to left side of neck, for 4-5 weeks; tapering down to moderate soreness on top of shoulder for 6+ weeks. At 7 weeks, top of shoulder and neck still uncomfortably sore.
Moderna vaccine for her first dose and the Pfizer vaccine for her second dose.; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Moderna vaccine for her first dose and the Pfizer vaccine for her second dose.) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Moderna vaccine for her first dose and the Pfizer vaccine for her second dose.). On 25-Mar-2021, INTERCHANGE OF VACCINE PRODUCTS (Moderna vaccine for her first dose and the Pfizer vaccine for her second dose.) outcome was unknown. Not Provided          Patient received the Moderna vaccine for her first dose and the Pfizer vaccine for her second dose. Patient received the Pfizer vaccine (lot: ER8732) in her right arm on 25 Mar 2021. No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD21-063217 (E2B Linked Report).; Sender's Comments:  MOD21-063217:Case of Husband
This spontaneous report was received from a nurse who refers to a patient of unknown age and gender. Medical history was not reported. The nurse informed that on 17-JUL-2014 the patient was vaccinated with M-M-R II (strength, dosage and route were not reported) lot number: J008728, expiration date: 26-JUL-2015. That may had been improperly stored since February 2014. The thermometer battery ran out in February 2014, so the refrigerator temperature was not able to be confirmed to be within recommended storage temperature since then. The highest temperature the M-M-R II could had been exposed was 70F. Also stated that was no way to determine what the exact temperature was at any given time after 01-FEB-2014 since the battery in the thermometer stopped working. No adverse effects reported. This is one of several reports received form the same reporter. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to multiple patients of unknown age and gender. The patients' concurrent condition, medical history or concomitant medications were not reported. On unknown dates, unspecified patients were vaccinated with improperly stored ZOSTAVAX lot # L012478, expiry date 10-JUL-2016 (dose and route of administration were unspecified). No adverse effects were reported. Additional information has been requested.
He has developed an extensive DVT in his left leg which is now very close to compromising the venous return of his renal transplant.  He had no history of clotting disorders or blood clots previously.  The only change in his usual activity was a plane ride less than three hours within the past month.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. On an unspecified date in 2012, the patient received complete series of RECOMBIVAX HB (dose, Lot # and route were not reported). This series "did not take". This was clarified that the patient was a no responder to series of vaccine. No adverse effects were noted. On an unknown date, the patient sought medical attention. No treatment was given. The outcome of the series of vaccine "did not take" and the patient was a non responder to series of vaccine was unknown. This is one of two reports from the same source. Additional information has been requested.
Eight and a half days after first vaccine shot I developed redness, warmth and mass at site of injection.   It is not tender and my arm is not sore.  It does NOT prevent me from doing any activities of daily living.  This is currently ongoing  but is dissipating on day 2.
Client states 5 min post vax, her arm started hurting and she has throbbing sensation that went down her left arm but it was not immobilizing, just felt like her arm was falling asleep. States she did not come back in the building. I stretched & extended her left arm and it helped it so she went on to work and someone told her to call the health department. She states her arm is just tingling now at 4:30. She has not taken Tylenol. PMP advised her to take Tylenol and apply ice to arm, today and apply heat tomorrow. Advised appointment with MD, ASAP, to evaluate if she should complete series, unless MD says, otherwise.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not reported. On 20-MAR-2017, the patient was vaccinated with an expired dose of PNEUMOVAX 23 (lot # L035686 and expiration date 16-FEB-2017) (dose, route and anatomical location were not reported) for prophylaxis. There were no previous temperature excursions. No adverse symptoms were reported. Additional information has been requested.
Pt dx with cellulitis.  +induration measuring 4cm X 2cm with some red streaking.  Pt tx'd with Cephalex.
A non-serious spontaneous report of inadvertent administration of expired H1N1 was received from a registered nurse/health professional concerning a eight-year-old female. Neither relevant medical history nor concomitant medications have been reported for this patient. The original expiration date was 08-Apr-2010, which was reassigned to 29-Mar-2010. On 31-Mar-2010, the patient received the second dose of expired H1N1, Intranasal for an unknown indication. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments were not applicable and the event was considered to be resolved.
72 hours, experienced Urticaria (Hives) on left posterior flank, bilateral forearm and legs. Legs symptoms has resolved as of now.
This is a spontaneous report from a contactable pharmacist. A 68-year-old patient of an unspecified gender started to receive PREVNAR 13  intramuscular on 01Dec2016 at single dose for immunisation. The patient medical history and concomitant medications were not reported. On 02Dec2016, the patient experienced redness, swelling and warm to touch at the injection site. The clinical outcome of events redness, and swelling at the injection site is recovering and the outcome for event warm to touch at the injection site was unknown. The action taken in response to the event for PREVNAR 13 was not applicable. Therapeutic measures were taken as a result of redness, swelling and warm to touch at the injection site as BENADRYL was used.
Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing; Initially felt like someone had sand papered by tongue; By 10am, I started having an allergic reaction; Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing; I also had itching on abdomen; Swelling through the body - rings wouldn't go on fingers; Had super sensitivity of tongue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPHAGIA (Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing), FEELING ABNORMAL (Initially felt like someone had sand papered by tongue), HYPERSENSITIVITY (By 10am, I started having an allergic reaction), PHARYNGEAL SWELLING (Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing) and PRURITUS (I also had itching on abdomen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy and Seasonal allergy. Concomitant products included ALPRAZOLAM and ESTRADIOL for an unknown indication.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPHAGIA (Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing), FEELING ABNORMAL (Initially felt like someone had sand papered by tongue), HYPERSENSITIVITY (By 10am, I started having an allergic reaction), PHARYNGEAL SWELLING (Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing), PRURITUS (I also had itching on abdomen), SWELLING (Swelling through the body - rings wouldn't go on fingers) and TONGUE DISCOMFORT (Had super sensitivity of tongue). At the time of the report, DYSPHAGIA (Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing), FEELING ABNORMAL (Initially felt like someone had sand papered by tongue), HYPERSENSITIVITY (By 10am, I started having an allergic reaction), PHARYNGEAL SWELLING (Swelling toward back of throat and epiglottis, really constricted, had trouble swallowing), PRURITUS (I also had itching on abdomen), SWELLING (Swelling through the body - rings wouldn't go on fingers) and TONGUE DISCOMFORT (Had super sensitivity of tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included Loratadine and Tylenol
Burn sensation accross tongue and oral mucosa including tongue, buccal mucosa, gums and mucosa between gums and lip.  Oral Epitheliolysis.  Loss of taste.
experiencing some arm pain where the injection was given; This was supposed to be under 70 Degrees Fahrenheit. They were keeping it out side and giving the injection; This was supposed to be under 70 Degrees Fahrenheit. They were keeping it out side and giving the injection; This is a spontaneous report from a contactable consumer (consumer). A 79-year-old male patient received first dose of BNT162B2 (lot number and expiry date not reported), via an unspecified route of administration on an unspecified date at single dose in the arm for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. This patient reports receiving his first injection of the Pfizer-BioNTech COVID-19 vaccine and experiencing some arm pain where the injection was given. Also he just noticed that when the nurse was going to give it to him that she had the syringe with the vaccine in it in her hand. She talked to him several minutes before administering. He thought this was supposed to be under 70 Degrees Fahrenheit. They were keeping it outside and giving the injection. He doesn't understand why they had it out in the weather. It was kind of warm in the state. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Mom put baby on back & baby choked, made gurgling sound & turned pale, stridorous breathing x 1 min;
patient became very lethargic immediately after receiving the 2nd dose of the vaccine.  Blood pressure rose to 190.  Patient fainted and hit her head.  She had just recovered from having covid-19.  She was diagnosed with covid-19 just after receiving her first immuniation.
Injection site pain, chills and muscular contractions, body aches  Patient took Tylenol and Benadryl and went to bed. Chills and contractions resolved within 4 hours.